| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P2093 | author name string | Ohashi Y | |
| Nakazato H | |||
| Hamada C | |||
| Sakamoto J | |||
| Kodaira S | |||
| P2860 | cites work | Effective surgical adjuvant therapy for high-risk rectal carcinoma | Q33387384 |
| The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials | Q34183760 | ||
| Cancer statistics, 1991. | Q35009044 | ||
| Adjuvant therapy of colorectal cancer. Why we still don't know | Q39642987 | ||
| Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa). | Q55043570 | ||
| P433 | issue | 2 | |
| P921 | main subject | chemotherapy | Q974135 |
| patient | Q181600 | ||
| colorectal carcinoma | Q25493920 | ||
| colorectal cancer | Q188874 | ||
| meta-analysis | Q815382 | ||
| P304 | page(s) | 78-86 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Japanese Journal of Clinical Oncology | Q2231629 |
| P1476 | title | Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials | |
| P478 | volume | 29 |
| Q24242231 | Adjuvant Therapy for completely resected Stage II Colon Cancer |
| Q33698724 | Adjuvant chemotherapy |
| Q36239072 | Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guideline |
| Q31106341 | An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. |
| Q36944056 | Cost-effectiveness of adjuvant chemotherapy with uracil-tegafur for curatively resected stage III rectal cancer |
| Q37709739 | Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials |
| Q33428086 | Efficacy and Safety of Capecitabine and Oxaliplatin (CapOX) as an Adjuvant Therapy in Japanese for Stage II/III Colon Cancer in a Group at High Risk of Recurrence in Retrospective Study |
| Q91828078 | Evaluation of Thymidylate Synthase Expression in Prostate Cancer |
| Q31016826 | Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. |
| Q44932713 | Patent blue staining as a method to improve lymph node detection in rectal cancer following neoadjuvant treatment |
| Q24201072 | Postoperative adjuvant chemotherapy in rectal cancer operated for cure |
| Q44744110 | Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial |
| Q46387437 | Quantitative lymph node evaluation as an independent marker of long-term prognosis in stage III rectal cancer. |
| Q79846295 | Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil |
| Q44115422 | Selective induction of colon cancer cell apoptosis by 5-fluorouracil in humans |
| Q33971420 | The role of meta-analyses in assessing cancer treatments |
| Q30557842 | Use of adjuvant chemotherapy in stage C (III) rectal cancer: Comparison of data from matched patients in a teaching hospital's clinico‐pathological database |
Search more.